Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 1.54 HKD 5.48%
Market Cap: HK$14.2B

Operating Margin

-6.6%
Current
Improving
by 6.4%
vs 3-y average of -13%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6.6%
=
Operating Income
¥-154m
/
Revenue
¥2.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6.6%
=
Operating Income
HK$-154m
/
Revenue
¥2.1B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
14.2B HKD
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

Lower than 77% of companies in China
Percentile
23nd
Based on 8 544 companies
23nd percentile
-6.6%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Sihuan Pharmaceutical Holdings Group Ltd
Glance View

Market Cap
14.2B HKD
Industry
Pharmaceuticals

Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 4,282 full-time employees. The company went IPO on 2010-10-28. The firm is mainly engaged in the research and development, manufacture and sales of pharmaceutical products in China. Its products are applicable in cardio-cerebral vascular (CCV) system, central nervous system, metabolism, oncology and anti-infective fields. Its CCV products include Kelinao, Anjieli and Oudimei, among others. Its non-CCV products include Ren’Ao, Metronidazole and Clindamycin, among others.

Intrinsic Value
0.5 HKD
Overvaluation 68%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-6.6%
=
Operating Income
¥-154m
/
Revenue
¥2.1B
What is Sihuan Pharmaceutical Holdings Group Ltd's current Operating Margin?

The current Operating Margin for Sihuan Pharmaceutical Holdings Group Ltd is -6.6%, which is above its 3-year median of -13%.

How has Operating Margin changed over time?

Over the last 3 years, Sihuan Pharmaceutical Holdings Group Ltd’s Operating Margin has decreased from -0.1% to -6.6%. During this period, it reached a low of -21.7% on Dec 31, 2022 and a high of -0.1% on Jun 30, 2022.

Back to Top